{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-021105","form_type":"8-K","ticker":"AIRE","cik":"0001859199","company_name":"reAlpha Tech Corp.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.583536+00:00","generated_at":"2026-05-15T23:11:53.822693+00:00","sec_items":["3.01","5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"reAlpha appoints Thomas Kutzman as CFO, resolves Nasdaq audit committee deficiency","bullets":["CEO Michael Logozzo and Prabhu Antony appointed to board Feb 24; Antony joins audit, compensation, nominating committees.","Audit committee now has three independent members, regaining Nasdaq Rule 5605(c)(2)(A) compliance.","Former CFO Piyush Phadke terminated Feb 25; Thomas Kutzman appointed CFO effective same day.","Kutzman receives $275k base salary, 66.7% annual bonus target, and equity eligibility under 2022 Plan.","Kutzman co-founded Prevu, served as reAlpha Realty CEO after Nov 2025 acquisition."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-021105","json":"https://secwatch.observer/filing/0001213900-26-021105.json","markdown":"https://secwatch.observer/filing/0001213900-26-021105.md","text":"https://secwatch.observer/filing/0001213900-26-021105.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026021105/0001213900-26-021105-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026021105/ea20260226-8k_realpha.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:11:53.822693+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6eb8480351aaeeeb08ba904ad84d3d209a3769f8","claim":"reAlpha Tech Corp. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)(B)).","evidence_excerpt":"February 6, 2026, the Company notified The Nasdaq Stock Market LLC (“Nasdaq”) of its non-compliance with Nasdaq Listing Rule 5605(c)(2)(A) and indicated its intention to rely on the cure period provided by Nasdaq Listing Rule 5605(c)(4)(B). Pursuant to Nasdaq Listing Rule 5605(c)(4)(B), the Company has a cure period to regain compliance until the earlier of the Company’s next annual meeting of stockholders and February 4, 2027. As disclosed in","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026021105/0001213900-26-021105-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"audit committee"},{"label":"Rules","value":"5605(c)(2)(A), 5605(c)(4)(B)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}